A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

When skin is cut or damaged, tiny cell fragments circulating in the blood, called platelets, arrive at the injury and spread out to stop the blood from leaking out. Once enough layers of platelets ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

This study identifies immature platelet fraction (IPF) as a moderate predictor for platelet recovery, enhancing our understanding of dengue management. The findings support IPF's clinical utility as ...

Please provide your email address to receive an email when new articles are posted on . Bentracimab restored platelet function in patients on ticagrelor with major bleeding or undergoing urgent ...